| MeSH term | MeSH ID | Detail |
|---|---|---|
| Weight Loss | D015431 | 56 associated lipids |
| Diabetes Mellitus, Type 1 | D003922 | 56 associated lipids |
| Cystic Fibrosis | D003550 | 65 associated lipids |
| Neuroblastoma | D009447 | 66 associated lipids |
| Liver Cirrhosis | D008103 | 67 associated lipids |
| Coronary Disease | D003327 | 70 associated lipids |
| Carcinoma, Non-Small-Cell Lung | D002289 | 72 associated lipids |
| Leukemia | D007938 | 74 associated lipids |
| Alzheimer Disease | D000544 | 76 associated lipids |
| Pancreatic Neoplasms | D010190 | 77 associated lipids |
7-octadecynoic acid
7-octadecynoic acid is a lipid of Fatty Acyls (FA) class.
Cross Reference
There are no associated biomedical information in the current reference collection.
Current reference collection contains 19785 references associated with 7-octadecynoic acid in LipidPedia. Due to lack of full text of references or no associated biomedical terms are recognized in our current text-mining method, we cannot extract any biomedical terms related to diseases, pathways, locations, functions, genes, lipids, and animal models from the associated reference collection.
Users can download the reference list at the bottom of this page and read the reference manually to find out biomedical information.
Here are additional resources we collected from PubChem and MeSH for 7-octadecynoic acid
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with 7-octadecynoic acid
All references with 7-octadecynoic acid
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Tobón-Arroyave SI et al. | Association of salivary levels of the bone remodelling regulators sRANKL and OPG with periodontal clinical status. | 2012 | J. Clin. Periodontol. | pmid:23039038 |
| Udomsuk L et al. | Impact of Pueraria candollei var. mirifica and its potent phytoestrogen miroestrol on expression of bone-specific genes in ovariectomized mice. | 2012 | Fitoterapia | pmid:23041523 |
| Xiang G et al. | Change of plasma osteoprotegerin and its association with endothelial dysfunction before and after exercise in Hashimoto's thyroiditis with euthyroidism. | 2012 | Exp. Clin. Endocrinol. Diabetes | pmid:23070830 |
| Lekva T et al. | TXNIP is highly regulated in bone biopsies from patients with endogenous Cushing's syndrome and related to bone turnover. | 2012 | Eur. J. Endocrinol. | pmid:22450549 |
| Wang D et al. | Accelerated calvarial healing in mice lacking Toll-like receptor 4. | 2012 | PLoS ONE | pmid:23071670 |
| Ming LG et al. | [Effect of osthol on apoptosis and bone resorption of osteoclasts cultured in vitro]. | 2012 | Yao Xue Xue Bao | pmid:22512027 |
| Chaves MD et al. | Bovine hydroxyapatite (Bio-Oss(®)) induces osteocalcin, RANK-L and osteoprotegerin expression in sinus lift of rabbits. | 2012 | J Craniomaxillofac Surg | pmid:22513050 |
| Koole D et al. | Osteoprotegerin is associated with aneurysm diameter and proteolysis in abdominal aortic aneurysm disease. | 2012 | Arterioscler. Thromb. Vasc. Biol. | pmid:22516062 |
| Rattazzi M et al. | Osteoprotegerin levels are increased in patients with venous thromboembolic disease. | 2012 | J. Thromb. Haemost. | pmid:22486966 |
| Ozkok A et al. | Osteoprotegerin/RANKL axis and progression of coronary artery calcification in hemodialysis patients. | 2012 | Clin J Am Soc Nephrol | pmid:22490874 |
| Funck-Brentano T et al. | Targeting bone alleviates osteoarthritis in osteopenic mice and modulates cartilage catabolism. | 2012 | PLoS ONE | pmid:22432033 |
| Robinson DE et al. | Glycosaminoglycan (GAG) binding surfaces for characterizing GAG-protein interactions. | 2012 | Biomaterials | pmid:22079008 |
| Aliprantis AO et al. | Transient muscle paralysis degrades bone via rapid osteoclastogenesis. | 2012 | FASEB J. | pmid:22125315 |
| Al-Sabbagh M et al. | Bone remodeling-associated salivary biomarker MIP-1α distinguishes periodontal disease from health. | 2012 | J. Periodont. Res. | pmid:22126530 |
| Talib A et al. | The balance of fetuin-A and osteoprotegerin is independently associated with diastolic dysfunction in hemodialysis patients. | 2012 | Hypertens. Res. | pmid:22129515 |
| Liang D et al. | Zinc upregulates the expression of osteoprotegerin in mouse osteoblasts MC3T3-E1 through PKC/MAPK pathways. | 2012 | Biol Trace Elem Res | pmid:22081405 |
| GarcÃa-Hernández A et al. | High glucose concentrations alter the biomineralization process in human osteoblastic cells. | 2012 | Bone | pmid:22086137 |
| Kühn MC et al. | Adipocyte-secreted factors increase osteoblast proliferation and the OPG/RANKL ratio to influence osteoclast formation. | 2012 | Mol. Cell. Endocrinol. | pmid:22040599 |
| Pineda B et al. | Effects of administration of hormone therapy or raloxifene on the immune system and on biochemical markers of bone remodeling. | 2012 | Menopause | pmid:22067277 |
| Chuang FH et al. | Long-term sequential receptor activator of NF-κB ligand (RANKL) and osteoprotegrin (OPG) expression in lipopolysaccharide-induced rat periapical lesions. | 2012 | J. Oral Pathol. Med. | pmid:21793936 |
| Jørgensen L et al. | Osteoprotegerin is associated with hip fracture incidence: the Tromso Study. | 2012 | Int J Epidemiol | pmid:22538253 |
| Motovska Z et al. | Circulating osteoprotegerin and Dickkopf-1 changed significantly after surgical aortic valve replacement but remained without any significant differences after transcatheter aortic valve implantation. | 2012 | Int. J. Cardiol. | pmid:22592030 |
| Güncü GN et al. | Effect of inflammation on cytokine levels and bone remodelling markers in peri-implant sulcus fluid: a preliminary report. | 2012 | Cytokine | pmid:22592038 |
| Helo S et al. | Role of denosumab in prostate cancer. | 2012 | Prostate Cancer Prostatic Dis. | pmid:22370723 |
| Røysland R et al. | Osteoprotegerin and cardiovascular mortality in patients with non-ST elevation acute coronary syndromes. | 2012 | Heart | pmid:22373720 |
| Brambila-Tapia AJ et al. | MTHFR C677T, MTHFR A1298C, and OPG A163G polymorphisms in Mexican patients with rheumatoid arthritis and osteoporosis. | 2012 | Dis. Markers | pmid:22377704 |
| Gimenez-Maitre A et al. | Deficit of osteoprotegerin release by osteoblasts from a patient with cystic fibrosis. | 2012 | Eur. Respir. J. | pmid:22379154 |
| Santos VR et al. | Partial- and full-mouth scaling and root planing in type 2 diabetic subjects: a 12-mo follow-up of clinical parameters and levels of cytokines and osteoclastogenesis-related factors. | 2012 | J. Periodont. Res. | pmid:21806617 |
| Kanbe K et al. | Osteoprotegerin expression in bone marrow by treatment with tocilizumab in rheumatoid arthritis. | 2012 | Rheumatol. Int. | pmid:21789615 |
| Oelzner P et al. | The balance between soluble receptors regulating IL-6 trans-signaling is predictive for the RANKL/osteoprotegerin ratio in postmenopausal women with rheumatoid arthritis. | 2012 | Rheumatol. Int. | pmid:20821212 |
| Liang W et al. | Icariin promotes bone formation via the BMP-2/Smad4 signal transduction pathway in the hFOB 1.19 human osteoblastic cell line. | 2012 | Int. J. Mol. Med. | pmid:22842877 |
| Dorota DK et al. | The concentrations of markers of bone turnover in normal pregnancy and preeclampsia. | 2012 | Hypertens Pregnancy | pmid:20822429 |
| Nanda KS et al. | Elevated circulating osteoprotegerin and reduced matrix-metalloprotease-9 in post-menopausal women with chronic Hepatitis C virus infection. | 2012 | Cytokine | pmid:22863720 |
| Dickerson TJ et al. | Rheumatoid and pyrophosphate arthritis synovial fibroblasts induce osteoclastogenesis independently of RANKL, TNF and IL-6. | 2012 | J. Autoimmun. | pmid:22867712 |
| Chao TH et al. | Opposite associations of osteoprotegerin and ZBTB40 polymorphisms with bone mineral density of the hip in postmenopausal Taiwanese women. | 2012 | J Chin Med Assoc | pmid:22824048 |
| Wang Y et al. | Inhibitory effect of adenovirus-mediated siRNA-targeting BMPR-IB on UHMWPE-induced bone destruction in the murine air pouch model. | 2012 | Connect. Tissue Res. | pmid:22827452 |
| Zhou WJ et al. | [Expression of receptor activator of NF-κB ligand and osteoprotegerin in peri-implant tissues during unloading period]. | 2012 | Zhonghua Kou Qiang Yi Xue Za Zhi | pmid:22883830 |
| Mayahara K et al. | Osteoblasts stimulate osteoclastogenesis via RANKL expression more strongly than periodontal ligament cells do in response to PGE(2). | 2012 | Arch. Oral Biol. | pmid:22884709 |
| Oka H et al. | Oral administration of prostaglandin E(2)-specific receptor 4 antagonist inhibits lipopolysaccharide-induced osteoclastogenesis in rat periodontal tissue. | 2012 | J. Periodontol. | pmid:21910594 |
| Korzon-Burakowska A et al. | Osteoprotegerin gene polymorphism in diabetic Charcot neuroarthropathy. | 2012 | Diabet. Med. | pmid:21913967 |
| Li YF et al. | The effects of combined human parathyroid hormone (1-34) and zoledronic acid treatment on fracture healing in osteoporotic rats. | 2012 | Osteoporos Int | pmid:21892678 |
| Lacey DL et al. | Bench to bedside: elucidation of the OPG-RANK-RANKL pathway and the development of denosumab. | 2012 | Nat Rev Drug Discov | pmid:22543469 |
| Campia U et al. | Osteoprotegerin and outcomes in acute coronary syndromes--when the culprit is not the plaque. | 2012 | Heart | pmid:22543836 |
| Choe WS et al. | Association between OPG, RANK and RANKL gene polymorphisms and susceptibility to acute coronary syndrome in Korean population. | 2012 | J. Genet. | pmid:22546829 |
| Bloch SL et al. | The viability of perilabyrinthine osteocytes: a quantitative study using bulk-stained undecalcified human temporal bones. | 2012 | Anat Rec (Hoboken) | pmid:22577084 |
| Tsubaki M et al. | Bisphosphonate- and statin-induced enhancement of OPG expression and inhibition of CD9, M-CSF, and RANKL expressions via inhibition of the Ras/MEK/ERK pathway and activation of p38MAPK in mouse bone marrow stromal cell line ST2. | 2012 | Mol. Cell. Endocrinol. | pmid:22579611 |
| Wang YD et al. | Dehydroepiandrosterone indirectly inhibits human osteoclastic resorption via activating osteoblastic viability by the MAPK pathway. | 2012 | Chin. Med. J. | pmid:22613593 |
| Ma Y et al. | Effects of brucine on bone metabolism in multiple myeloma. | 2012 | Mol Med Rep | pmid:22614932 |
| Ma D et al. | Smoke-induced signal molecules in bone marrow cells from altered low-density lipoprotein receptor-related protein 5 mice. | 2012 | J. Proteome Res. | pmid:22616666 |
| Kim EC et al. | Lysyl oxidase and the lysyl oxidase-like protein modulate odontoblastic differentiation of human dental pulp cells. | 2012 | J Endod | pmid:22595110 |
| da Silva RA et al. | Toll-like receptor 2 knockout mice showed increased periapical lesion size and osteoclast number. | 2012 | J Endod | pmid:22595116 |
| Canon J et al. | RANKL inhibition combined with tamoxifen treatment increases anti-tumor efficacy and prevents tumor-induced bone destruction in an estrogen receptor-positive breast cancer bone metastasis model. | 2012 | Breast Cancer Res. Treat. | pmid:22926264 |
| Shuid AN et al. | Eurycoma longifolia upregulates osteoprotegerin gene expression in androgen- deficient osteoporosis rat model. | 2012 | BMC Complement Altern Med | pmid:22967165 |
| Sakai N et al. | Receptor activator of nuclear factor-κB ligand (RANKL) protects against hepatic ischemia/reperfusion injury in mice. | 2012 | Hepatology | pmid:22031462 |
| Fichna M et al. | Increased serum osteoprotegerin in patients with primary adrenal insufficiency receiving conventional hydrocortisone substitution. | 2012 | J. Physiol. Pharmacol. | pmid:23388484 |
| Sanchez C et al. | Regulation of subchondral bone osteoblast metabolism by cyclic compression. | 2012 | Arthritis Rheum. | pmid:22034083 |
| Torchinsky A et al. | Bone loss in adult offspring induced by low-dose exposure to teratogens. | 2012 | J. Bone Miner. Metab. | pmid:21960178 |
| Schweikle E et al. | Osteoprotegerin positively regulates hematopoietic progenitor cells. | 2012 | Curr Stem Cell Res Ther | pmid:22023625 |
| Rimondi E et al. | Hydrogen sulfide down-regulates the expression and release of osteoprotegerin (OPG) by vascular endothelial cells. | 2012 | Invest New Drugs | pmid:21541705 |
| Tibullo D et al. | Effects of second-generation tyrosine kinase inhibitors towards osteogenic differentiation of human mesenchymal cells of healthy donors. | 2012 | Hematol Oncol | pmid:21544849 |
| Hulin-Curtis SL et al. | Tumour necrosis factor receptor superfamily member 11B polymorphisms and association with knee osteoarthritis in women. | 2012 | Int. J. Immunogenet. | pmid:22296645 |
| Fitzgerald O and Chandran V | Update on biomarkers in psoriatic arthritis: a report from the GRAPPA 2010 annual meeting. | 2012 | J. Rheumatol. | pmid:22298273 |
| Silva JA et al. | Periodontal disease-associated compensatory expression of osteoprotegerin is lost in type 1 diabetes mellitus and correlates with alveolar bone destruction by regulating osteoclastogenesis. | 2012 | Cells Tissues Organs (Print) | pmid:22301390 |
| Gradosova I et al. | Protective effect of amlodipine on rat bone tissue after orchidectomy. | 2012 | Pharmacology | pmid:22302040 |
| Kennedy OD et al. | Activation of resorption in fatigue-loaded bone involves both apoptosis and active pro-osteoclastogenic signaling by distinct osteocyte populations. | 2012 | Bone | pmid:22342796 |
| Leistner DM et al. | Elevated levels of the mediator of catabolic bone remodeling RANKL in the bone marrow environment link chronic heart failure with osteoporosis. | 2012 | Circ Heart Fail | pmid:22936827 |
| Liu T et al. | [Correlation between local microenvironment leptin expression and avascular necrosis of the femoral head]. | 2012 | Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi | pmid:23230665 |
| Li L et al. | [Progress of osteogenic effect of strontium and its application in orthopaedics]. | 2012 | Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi | pmid:23230680 |
| Qiu S et al. | [Design and activity verification of human parathyroid hormone (1-34) mutant protein]. | 2012 | Yao Xue Xue Bao | pmid:22993856 |
| Vik A et al. | Serum osteoprotegerin and future risk of venous thromboembolism. The Tromsø study. | 2012 | Thromb. Res. | pmid:22909822 |
| Feng Q et al. | [Effect of sonicated extracts of Porphyromonas gingivalis on receptor activator of NF-κB ligand and osteoprotegerin expression in periodontal ligament cells]. | 2012 | Zhonghua Kou Qiang Yi Xue Za Zhi | pmid:23302383 |
| Yan J et al. | Spinal cord injury causes bone loss through peroxisome proliferator-activated receptor-γ and Wnt signalling. | 2012 | J. Cell. Mol. Med. | pmid:22947224 |
| Mlakar SJ et al. | Testing GSTP1 genotypes and haplotypes interactions in Slovenian post-/pre-menopausal women: novel involvement of glutathione S-transferases in bone remodeling process. | 2012 | Maturitas | pmid:22221655 |
| Kadkhodazadeh M et al. | Analysis of osteoprotegerin (OPG) gene polymorphism in Iranian patients with chronic periodontitis and peri-implantitis. A cross-sectional study. | 2012 | Eur J Oral Implantol | pmid:23304691 |
| Curl L et al. | A pharmacodynamic investigation into the efficacy of osteoprotegerin during aseptic inflammation. | 2012 | Aust Orthod J | pmid:23304971 |
| Emanuele E et al. | Linking atherosclerosis to Alzheimer's disease: focus on biomarkers. | 2012 | Front Biosci (Elite Ed) | pmid:22201906 |
| Karatolios K et al. | Osteoprotegerin (OPG) and TNF-related apoptosis-inducing ligand (TRAIL) levels in malignant and benign pericardial effusions. | 2012 | Clin. Biochem. | pmid:22202560 |
| Delgado-Calle J et al. | Role of DNA methylation in the regulation of the RANKL-OPG system in human bone. | 2012 | Epigenetics | pmid:22207352 |
| Bao L et al. | Adeno-associated virus-mediated osteoprotegerin gene transfer protects against joint destruction in a collagen-induced arthritis rat model. | 2012 | Joint Bone Spine | pmid:22154615 |
| Shahnazari M et al. | Bone turnover markers in peripheral blood and marrow plasma reflect trabecular bone loss but not endocortical expansion in aging mice. | 2012 | Bone | pmid:22154841 |
| Zheng CM et al. | Association between increased serum osteoprotegerin levels and improvement in bone mineral density after parathyroidectomy in hemodialysis patients. | 2012 | Tohoku J. Exp. Med. | pmid:22156488 |
| Said F et al. | The effect of etidronate on the periodontium of ovariectomized rats. | 2012 | J. Periodontol. | pmid:22166164 |
| Upton AR et al. | The expression of RANKL and OPG in the various grades of osteoarthritic cartilage. | 2012 | Rheumatol. Int. | pmid:21259010 |
| Kaneko K et al. | Changes of serum soluble receptor activator for nuclear factor-κB ligand after glucocorticoid therapy reflect regulation of its expression by osteoblasts. | 2012 | J. Clin. Endocrinol. Metab. | pmid:22791764 |
| Çanga A et al. | Elevated serum osteoprotegerin levels predict in-hospital major adverse cardiac events in patients with ST elevation myocardial infarction. | 2012 | J Cardiol | pmid:22727437 |
| Yoon WJ et al. | Sargachromanol G regulates the expression of osteoclastogenic factors in human osteoblast-like MG-63 cells. | 2012 | Food Chem. Toxicol. | pmid:22727857 |
| Miyaji Y et al. | Novel comb-shaped PEG modification enhances the osteoclastic inhibitory effect and bone delivery of osteoprotegerin after intravenous administration in ovariectomized rats. | 2012 | Pharm. Res. | pmid:22729371 |
| Khoury N et al. | Resorptive hypercalcemia in post-essential thrombocythemia myelofibrosis: treatment with denosumab. | 2012 | J. Clin. Endocrinol. Metab. | pmid:22730513 |
| Oue E et al. | CXCL2 synthesized by oral squamous cell carcinoma is involved in cancer-associated bone destruction. | 2012 | Biochem. Biophys. Res. Commun. | pmid:22771802 |
| Bilgin E et al. | Markers of bone metastases in breast and lung cancers. | 2012 | Asian Pac. J. Cancer Prev. | pmid:23167338 |
| Luo ZR and Xie QJ | [Correlation between osteoprotegerin gene 209G/A, 245T/G and 1181G/C polymorphism and acute coronary syndromes in Han people of Fujian area]. | 2012 | Zhongguo Wei Zhong Bing Ji Jiu Yi Xue | pmid:23168201 |
| Cui L et al. | Effect of fluid flow-induced shear stress on osteoclast formation induced by osteocyte. | 2012 | Zhongguo Yi Xue Ke Xue Yuan Xue Bao | pmid:22776650 |
| Tyagi AM et al. | Formononetin reverses established osteopenia in adult ovariectomized rats. | 2012 | Menopause | pmid:22781783 |
| Yao Y et al. | [The effect of bone morphogenetic protein-2 and osteoprotegerin in trans-sutural distraction osteogenesis]. | 2012 | Hua Xi Kou Qiang Yi Xue Za Zhi | pmid:22934505 |
| Zhang M et al. | [The expression and significance of receptor activator of nuclear factor kappaB ligand and osteoprotegerin in periapical cyst and periapical granuloma]. | 2012 | Hua Xi Kou Qiang Yi Xue Za Zhi | pmid:22934488 |
| Tenta R et al. | Association between circulating levels of adiponectin and indices of bone mass and bone metabolism in middle-aged post-menopausal women. | 2012 | J. Endocrinol. Invest. | pmid:21606670 |
| Liu L et al. | [Effect of gradually induced disordered occlusion on the expression of osteoprotegerin and receptor activator of nuclear factor-kappaB ligand in mandibular condylar cartilage of rats]. | 2012 | Hua Xi Kou Qiang Yi Xue Za Zhi | pmid:22594224 |
| Zhou W et al. | [Expression of receptor activator nuclear factor kappa B ligand and osteoprotegerin in peri-implant soft tissue and bone tissue]. | 2012 | Hua Xi Kou Qiang Yi Xue Za Zhi | pmid:22389960 |
| Histing T et al. | Increased osteoblast and osteoclast activity in female senescence-accelerated, osteoporotic SAMP6 mice during fracture healing. | 2012 | J. Surg. Res. | pmid:21571305 |
| Taddei SR et al. | Experimental model of tooth movement in mice: a standardized protocol for studying bone remodeling under compression and tensile strains. | 2012 | J Biomech | pmid:23036306 |